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Abstract
Introduction:  Laryngeal  involvement  by  cartilaginous  tumors  is  rare.  However,  although
accounting  for  only  1%  of  laryngeal  tumor  pathology,  they  are  the  most  frequently  occurring
non-epithelial  neoplasms.  The  most  probable  location  is  the  endolaryngeal  surface  of  the  cricoid
cartilage. Their  symptoms  are  variable,  depending  on  the  size  and  location,  and  may  include
hoarseness,  stridor,  and  dyspnea.  Treatment  is  based  on  surgical  excision.  Some  centers  take
into account  the  degree  of  differentiation  and  whether  it  is  a  case  of  relapse  when  deciding  to
perform a  radical  resection.
Aim:  To  evaluate  this  disease  in  a  sample  of  the  Portuguese  population.
Methods:  A  review  of  the  medical  records  from  2002  to  2012  by  assessment  of  clinical  processes
was performed.  Data  on  demographics,  clinical  treatments,  and  outcomes  were  collected.
Results:  Six  patients  were  included  in  the  study.  Five  of  them  underwent  total  laryngectomy,
and in  one  case,  partial  excision  of  the  thyroid  cartilage  was  performed.  None  of  the  patients
had either  metastases  or  tumor-related  death.
Conclusion:  Laryngeal  chondrosarcomas  remain  a  rare  disease  of  unknown  etiology,  with  slow
and insidious  symptoms.  The  treatment  is  surgical,  with  favorable  prognosis,  and  metastases
rarely occur.  The  main  concern  regards  their  propensity  to  relapse.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
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PALAVRAS-CHAVE
Condrossarcoma;
Doenc¸as  da  laringe;
Eoplasias  laríngeas
Condrossarcoma  da  laringe  --  10  anos  de  casuística
Resumo
Introduc¸ão:  O  acometimento  laríngeo  por  tumores  cartilaginosos  é  raro.  No  entanto,  apesar
de representarem  1%  da  patologia  tumoral  laríngea,  são  as  neoplasias  não  epiteliais  mais  fre-
quentes.  Localizam-se  mais  frequentemente  na  face  endolaríngea  da  cartilagem  cricóide.  Tem
sintomatologia  variável  consoante  o  tamanho  e  a  localizac¸ão,  podendo  incluir  disfonia,  estridor
e dispneia.  O  tratamento  é  essencialmente  cirúrgico.  Alguns  centros  levam  em  conta  o  grau  de
diferenciac¸ão e  de  se  tratar  ou  não  de  recidiva,  quando  da  decisão  de  ressecc¸ão  mais  ou  menos
radical.
Objetivo:  Avaliar  esta  patologia  numa  amostra  da  populac¸ão  portuguesa.
Método:  Revisão  da  casuística  no  intervalo  de  tempo  2002-2012,  através  de  consulta  dos  pro-
cessos clínicos.  Foram  coligidos  os  dados  demográﬁcos  e  clínicos  relevantes,  os  tratamentos
efetuados  e  os  resultados.
Resultados:  Foram  incluídos  seis  pacientes.  Cinco  foram  submetidos  à  laringectomia  total  e  um
foi submetido  à  excisão  da  asa  esquerda  da  cartilagem  tiroide.  Nenhum  apresentou  metástases
ou morte  relacionada  com  o  tumor.
Conclusão:  Os  condrossarcomas  laríngeos  permanecem  como  patologia  rara,  de  etiologia
desconhecida,  com  crescimento  lento  e  clínica  insidiosa.  O  tratamento  é  cirúrgico,  com  prognós-
tico favorável,  com  a  metastizac¸ão  a  ocorrer  raramente.  A  maior  preocupac¸ão  decorre  da  sua
propensão à  recidiva.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Rare  and  insidious  pathological  entities  require  extra
attention  for  their  appropriate  diagnosis  and  treatment.
Laryngeal  involvement  by  cartilaginous  tumors  is  rare.1--4
However,  despite  representing  only  1%  of  laryngeal  tumor
pathology,  they  are  the  most  frequently  occurring  non-
epithelial  neoplasms.2 Chondromas  are  the  most  common
benign  tumors,  most  often  affecting  the  cricoid  cartilage
(75%).3 Only  approximately  0.1%  of  cartilaginous  tumors  are
chondrosarcomas,  which  are  most  commonly  low  grade.1,2,5
Chondrosarcoma  is  a  slow-growing  malignant  tumor,  most
commonly  located  in  the  pelvis,  femur,  ribcage,  humerus,
scapula,  ﬁbula,  sacrum,  and  sternum.  More  rarely,  it  is
found  in  the  head  and  neck,  in  approximately  10--20%  of
the  total  number  of  cases.2,5 In  the  larynxchondromas  they
are  located  in  most  cases  in  the  endolaryngeal  surface  of  the
posterior  portion  of  the  cricoid  cartilage.1,2,5,6 It  less  often
affects  the  arytenoid  cartilage  or  the  thyroid  cartilage  in  the
inferior  border  of  its  laryngeal  surface.5,7
Its  etiology  remains  unknown,  but  there  are  some
hypotheses  regarding  the  contribution  of  medullary-cervical
trauma  and  vertebral  instability,3 repeated  laryngeal
trauma,5 radiotherapy,  Teﬂon® injection,6 and  irregular  ossi-
ﬁcation  of  laryngeal  cartilage.7
As  for  the  epidemiological  characteristics,  it  is  most  often
observed  in  adult  patients  in  the  sixth  and  seventh  decades
of  life,1 although  it  can  be  found  at  any  age.  It  affects  more
males  than  females,  at  a  ratio  of  3:1.3 Cartilaginous  tumors
with  higher  degrees  of  malignancy  are  found  at  older  ages.6Symptoms  are  variable  and  depend  on  tumor  size  and
location.  Tumors  may  be  asymptomatic  while  small,  and
their  growth  can  trigger  dysphonia,  stridor,  dyspnea,  and
c
d
oysphagia.  The  clinical  picture  very  rarely  includes  pain.1,3,5
here  have  been  cases  described  with  concurrent  vocal
ord  paralysis,  which  is  thought  to  originate  from  cricoary-
enoid  joint  ﬁxation  and  not  the  recurrent  laryngeal  nerve
esion.1
Endoscopic  assessment  must  be  considered,  taking  into
ccount  the  tumor’s  common  subglottic  location.  The  clin-
cian  must  search  for  submucosal  bulging,  usually  with
egular  mucosa  and  in  a  more  posterior  location,  which  is
mall-sized  (usually  smaller  than  3--4  cm).5 Vocal  cord  immo-
ilization  can  be  found.
During  imaging  assessment  and  in  the  presence  of  larger
asses,  an  anterior  displacement  of  the  larynx  in  the  lateral
ervical  radiograph  can  be  observed.  However,  its  clinical
uspicion  requires  the  performance  of  computed  tomogra-
hy  (CT)  or  magnetic  resonance  imaging  (MRI).  Some  authors
uggest  that  CT  is  the  imaging  examination  of  choice,1--3,8
isclosing  a  hypodense,  well-deﬁned  image  with  calciﬁca-
ions  inside,  cartilage  destruction,  and  structure  distortion.9
Others  report  the  superiority  of  MRI  due  to  its  greater
ccuracy  in  distinguishing  between  tumor  and  other  para-
aryngeal  tissues.5,8 The  signal  strength  is  low  on  T1
nd  high  on  T2,  with  a  characteristic  mosaic  pattern.8
he  F-18  ﬂuorodeoxyglucose-positron  emission  tomogra-
hy  (FDG-PET)  is  helpful  in  tumor  grading,  metastasis
etection,  and  local  recurrence  assessment.  The  uptake
alue  of  1.3  was  set  as  the  limit  between  benign  and
alignant  lesions,  with  the  higher  uptake  showing  greater
ifferentiation.8,10
In  spite  of  clinical  suspicion  and  the  above-mentioned
omplementary  diagnostic  tests,  the  diagnosis  can  only  be
eﬁnitely  established  by  histological  study.  Often,  this  can
nly  be  correctly  achieved  through  the  study  of  the  surgical
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Table  1  Summary  of  case  series:  patients  with  laryngeal  chondrosarcoma  (2002--2012).
Age  (A)  73  56  73  70  50  50
Gender F  F  M  M  M  F
Initial symptom  Dysphonia
Dyspnea
Dysphagia
Coughing
Dysphonia  Dysphonia  Dysphonia  Dysphonia
Treatment TL  Excision  of  left
side  of  thyroid  C
TL  TL  TL  TL
Location Cricoid  C  Thyroid  C  Cricoid  C  Cricoid  C  and  left
arytenoid  C
Cricoid  C  Cricoid  C
Histopathology  Chondrosarcoma
Grade  III
Chondrosarcoma
Grade  II
Chondrosarcoma
Grade  II
Chondrosarcoma
Grade  I
Chondrosarcoma  Grade  I  Chondrosarcoma
Grade  I
Additional treatment  --  --  Adjuvant  RT  Adjuvant  RT  --  --
Metastases/Recurrence  --  --  --  --  --  --
Follow-up (A)  7  6  5  2  <1  5
Age (A -- years), considered at the time of diagnosis; M, male; F, female; TL, total laryngectomy; C, cartilage; RT, radiotherapy.
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specimen,  as  endoscopy  biopsies  may  be  inconclusive  due  to
the  difﬁculty  of  handling  a  submucosal  pathology.1,5
Histological  analysis  discloses  hyaline  cartilage,  with
giant  cartilage  cells,  pleomorphism,  and  hyperchromatic
nuclei.  The  differential  diagnosis  is  made  with  chondroma,
ﬁbrosarcoma,  osteosarcoma,  and  chondromyxoid  ﬁbroma.
According  to  the  cell  differentiation  degree  on  histopatho-
logical  ﬁndings  (mitotic  index,  cellularity,  and  nuclear  size),
laryngeal  chondrosarcoma  is  graded  according  to  the  clas-
siﬁcation  proposed  in  1943  by  Jaffe  and  Lichtenstein  for
chondrosarcomas  of  long  bones  and  updated  in  1977  by  Evans
et  al.,  sub-divided  into  three  grades  (I--III).
Most  authors  reported  difﬁculty  in  differentiating  low-
grade  chondrosarcomas  (I)  from  chondromas  (benign
tumors)  due  to  the  absence  of  mitotic  activity,  presence
of  small  nuclei,  chondroid  intercellular  space,  and  frequent
calciﬁcations.  Lesion  size  can  help  in  the  differentiation,
because  the  chondroma  is  usually  smaller  than  the  chon-
drosarcoma.  The  diagnosis  becomes  easier  in  grade  II  due
to  the  presence  of  larger  nuclei,  myxoid  intercellular  space,
and  low  mitotic  index;  and  in  grade  III,  due  to  higher  mitotic
index  and  nuclear  atypia.2,5,6
Laryngeal  chondrosarcomas  are  less  aggressive  in  the  lar-
ynx  than  in  other  locations;  they  are  slow-growth  tumors,
more  commonly  diagnosed  in  the  early  stages  of  differen-
tiation.  Moreover,  metastases  rarely  occur  (8.5%)5;  when
they  occur,  they  are  more  often  found  in  the  lungs  and
skeleton.
The  treatment  is  based  mainly  on  surgical  excision,  which
can  be  achieved  endoscopically  or  by  open  technique.1
Endoscopic  treatment  is  usually  limited  to  smaller
lesions.  The  use  of  laser  therapy  allows  for  a  better  control
of  bleeding,  and  three  types  can  be  used.  The  CO2 laser  is
more  indicated  for  cases  involving  stenosis.  The  potassium-
titanyl-phosphate  (KTP)  laser  is  absorbed  by  hemoglobin,
provides  good  electrocoagulation,  and  does  not  penetrate
deeply  into  tissues.  It  is  more  useful  in  cases  of  lesions
encroaching  into  the  lumen.  The  neodymium-doped  yttrium
aluminum  garnet  (Nd:YAG)  laser  is  absorbed  by  tissues,
allowing  for  an  appropriate  deeper  resection,  even  in  the
presence  of  ossiﬁcation.11 When  performing  the  conven-
tional  technique,  the  clinician  can  be  more  or  less  radical,
with  some  centers  taking  into  account  the  degree  of  dif-
ferentiation  and  whether  or  not  to  treat  recurrence.  In
cases  of  advanced  lesions,  in  which  total  lesion  removal
is  unlikely,  or  when  there  is  inﬁltration  of  surrounding  tis-
sues  or  an  advanced  degree  of  differentiation/malignancy,
or  in  cases  of  recurrence,  total  laryngectomy  should  be
performed.1,5,10
Due  to  its  low  radiosensitivity,  the  role  of  radiotherapy
is  controversial,  and  is  not  part  of  the  ﬁrst-line  treat-
ment.  It  is  reserved  for  cases  of  recurrence,  extensive  and
aggressive  lesions,  or  even  inoperable  ones.1,2,5 Chemother-
apy  is  not  widely  employed  due  to  the  rare  occurrence  of
metastases.2,5
Most  authors  report  a  tendency  to  recur  in  about  35--40%
of  cases.2 This  entity  usually  has  good  prognosis,  with  a  sur-
vival  rate  of  95%  at  ten  years,  although  lesion  size,  degree
of  differentiation,  and  whether  a  radical  surgical  procedure
was  performed  should  be  taken  into  account.1,2 The  follow-
up  is  necessarily  long,  lasting  over  ﬁve  years  due  to  the
tendency  of  late  recurrence.7357
aterials and methods
he  present  study  involves  a  review  of  chondrosarcoma
ases  from  2002  to  2012,  through  the  review  of  clini-
al  processes.  Demographics  and  relevant  data  on  clinical
haracteristics,  treatments  performed,  and  outcomes  were
ollected.
esults
ix  patients  were  included  in  the  study,  three  males  and
hree  females  (Table  1).  The  mean  age  at  diagnosis  was
2  years,  ranging  from  50  to  73  years.  The  most  com-
on  symptom  was  dysphonia  (for  more  than  one  year).
otal  laryngectomy  was  performed  in  ﬁve  patients,  and  one
atient  was  submitted  to  excision  of  the  left  portion  of  the
hyroid  cartilage.  Radiotherapy  was  used  as  adjuvant  ther-
py  in  two  cases.  The  histological  analysis  showed  three
rade  I chondrosarcomas,  two  grade  II,  and  one  grade  III.
he  most  frequent  location  was  the  cricoid  cartilage.  In  this
eries,  there  were  no  patients  with  metastases  or  whose
eath  was  tumor-related.  The  mean  follow-up  was  4.16
ears,  ranging  from  zero  to  seven  years.
onclusion
aryngeal  chondrosarcoma  is  a  rare  disorder  of  unknown  eti-
logy,  with  slow  growth  and  insidious  clinical  picture.  The
ccurrence  of  distant  metastases  is  rare.  A  high  degree  of
uspicion  is  required  for  early  detection.  Treatment  is  based
n  surgical  excision,  with  a  favorable  prognosis.  Although
arely  possible,  considering  the  usual  location  of  these
umors  in  the  posterior  surface  of  the  cricoid  cartilage,
aryngeal  function  should  be  preserved.  The  main  concern
egarding  these  tumors  is  their  propensity  to  relapse,  which
sually  occurs  at  a  later  stage,  making  long-term  surveil-
ance  mandatory.
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